Headline News about Genmab A/S ADR
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
4 Analysts Assess Genmab: What You Need To Know
February 20, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Genmab
February 13, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Cracking The Code: Understanding Analyst Reviews For Genmab
January 29, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
9 Analysts Have This to Say About Genmab
November 28, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2024/Gavel-law-Image-by-Okan-Caliskan-from-Pi_2.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/oracle_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://investorplace.com/wp-content/uploads/2019/07/cheap-retail-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Genmab's Future
November 08, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
What 13 Analyst Ratings Have To Say About Genmab
October 13, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/10/18/united_airlines_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Expert Ratings for Genmab
September 26, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Genmab's Future
September 05, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/747719/radiologist-of-oncology-institute-is-examing-mri-scans.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/11/azn_1.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/746579/biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/05/sgen.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.